<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-7459</journal-id>
<journal-title><![CDATA[Horizonte sanitario]]></journal-title>
<abbrev-journal-title><![CDATA[Horiz. sanitario]]></abbrev-journal-title>
<issn>2007-7459</issn>
<publisher>
<publisher-name><![CDATA[Universidad Juárez Autónoma de Tabasco, División Académica de Ciencias de la Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-74592019000200127</article-id>
<article-id pub-id-type="doi">10.19136/hs.a18n2.2661</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Perception of empowerment and therapeutic adherence in type 2 diabetes and glycemic control in patients of a primary health care unit from Tabasco, Mexico]]></article-title>
<article-title xml:lang="es"><![CDATA[Percepción de empoderamiento y adherencia terapéutica en DT2 y control glucémico en pacientes de una unidad de atención primaria de Tabasco, México]]></article-title>
<article-title xml:lang="fr"><![CDATA[Perception de l&#8217;autonomisation et de l&#8217;adhérence thérapeutique dans DT2 et contrôle glycémique chez les patients d&#8217;une unité de soins primaires à Tabasco, au Mexique]]></article-title>
<article-title xml:lang="pt"><![CDATA[Percepçâo de empoderamento e adesâo terapéutica no DT2 e controle glicêmico em pacientes de uma unidade de atençâo primária em Tabasco, México]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Burelo]]></surname>
<given-names><![CDATA[María del Rosario]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Avalos García]]></surname>
<given-names><![CDATA[María Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Garrido Pérez]]></surname>
<given-names><![CDATA[Silvia María Guadalupe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Ramón]]></surname>
<given-names><![CDATA[Concepción]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Ministry of Health  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Ministry of Health  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Mexican Social Security Institute  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Mexican Social Security Institute  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2019</year>
</pub-date>
<volume>18</volume>
<numero>2</numero>
<fpage>127</fpage>
<lpage>137</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-74592019000200127&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-74592019000200127&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-74592019000200127&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Sumary:  Objective:  To analyze the perception of empowerment and therapeutic adherence in patients with Type 2 Diabetes and their glycemic control in a primary care unit in Tabasco, Mexico.  Materials and methods:  Observational, cross-sectional and analytical study in a sample of 100 patients with diabetes. We analyzed variables of perception of empowerment, therapeutic adherence, sociodemographic and clinical. As a dependent variable, the figure of glycosylated hemoglobin HgAlc was taken as the gold standard of metabolic control. An instrument integrated by the DES-28 scale was applied to assess perception of empowerment, a questionnaire to assess the perception of Adherence of Bayarre-Grau. For the analysis, descriptive and inferential statistics (Pearson&#8217;s X2) were used with the SPSS V22.0 software.  Results:  The patients with diabetes were women 72%, average of age 56 years, married 60%, housewives 68%, primary studies 43%, average BMI 30.8, average of years with diabetes 8.9, main complication diabetic neuropathy 61% , mean of HgA1 figure of 8.675%, with HgA1 figure altered 82%, patients perceived to be empowered were 86%, of these, 80.2% showed lack of control with an x2 of 1,300 and a value of p = .000, with adherence 84%, of these patients resulted with altered glycemic control 83.3% with an X2.632 and a value of p = .000.  Conclusions:  Patients who feel empowered and adherent to treatment in our study have inadequate glycemic control, which allows us to conclude that it is necessary to investigate other factors that go beyond perception and an area of opportunity would be to implement effective strategies to achieve results successful.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo:  Analizar la percepción de empoderamiento y adherencia terapéutica en pacientes con Diabetes Tipo 2 y su control glucémico en una unidad de atención primaria de Tabasco, México.  Mteriales y métodos:  Estudio observacional, transversal y analítico, en una muestra de 100 pacientes con diabetes. Se analizaron variables de percepción del empoderamiento, adherencia terapéutica, sociodemográficas y clínicas. Como variable dependiente se tomó la cifra de Hemoglobina glicosilada HgAlc como estándar de oro del control metabólico. Se aplicó un instrumento integrado por la escala DES-28 para evaluar percepción del empoderamiento, cuestionario para evaluar percepción de Adherencia de Bayarre-Grau. Para el análisis se utilizó estadística descriptiva e inferencial (X2 de Pearson) con el software SPSS V22.0.  Resultados:  Los pacientes con diabetes fueron mujeres 72%, media de edad 56 años, casadas 60%, amas de casa 68%, estudios de primaria 43%, IMC promedio 30.8, promedio de años con diabetes 8.9, principal complicación neuropatía diabética 61%, media de cifra de HgAl de 8.675%, con cifra de HgAl alterada 82%, pacientes que se perciben empoderados fueron 86%, de estos, presentaron descontrol el 80.2% con una x2 de 1.300 y un valor de p=.000, con adherencia 84%, de estos pacientes resultaron con un control glucémico alterado el 83.3% con una x2 .632 y un valor de p=.000.  Conclusiones:  Los pacientes que se perciben empoderados y adherentes al tratamiento en nuestro estudio presentan un control glucémico inadecuado, lo que permite concluir que es necesario investigar otros factores que van más allá de la percepción y un área de oportunidad sería implementar estrategias efectivas para lograr resultados exitosos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="fr"><p><![CDATA[Résumé:  Objectif:  Analyser la perception de l&#8217;autonomisation et de l&#8217;adhérence thérapeutique chez les patients atteints de diabète de type 2 et leur contrôle glycémique dans une unité de soins primaires à Tabasco, au Mexique.  Matériaux et méthodes:  Étude observationnelle, transversale et analytique sur un échantillon de 100 patients diabétiques. Nous avons analysé des variables de perception de l&#8217;autonomisation, de l&#8217;adhérence thérapeutique, sociodémographique et clinique. En tant que variable dépendante, la valeur de l&#8217;hémoglobine glycosylée HgA1c a été prise comme critère de référence du contrôle métabolique. Un instrument intégré à l&#8217;échelle DES-28 a été utilisé pour évaluer la perception de l&#8217;autonomisation, un questionnaire pour évaluer la perception de l&#8217;adhésion de Bayarre-Grau. Pour l&#8217;analyse, des statistiques descriptives et inférentielles (X2 de Pearson) ont été utilisées avec le logiciel SPSS V22.0.  Résultats:  Les patients diabétiques étaient des femmes 72%, âge moyen 56 ans, marié 60%, les femmes au foyer 68%, l&#8217;enseignement primaire 43%, IMC moyen de 30,8, la durée moyenne du diabète avec 8,9, complication majeure neuropathie diabétique 61% , chiffre moyen de 8,675% hgAl avec la figure altérée hgAl 82% des patients étaient perçus habilitée 86% de ceux-ci, 80,2% avaient incontrôlée avec x2 1300 et une valeur de p = 0,000, avec 84% de ces patients ont présenté un contrôle glycémique altéré de 83,3% avec une valeur de x2,632 et une valeur de p = 0,000.  Conclusions:  Les patients responsabilisés et adhérents sont perçus à un traitement dans notre étude ont un contrôle glycémique insuffisant, ce qui conduit à la conclusion qu&#8217;il est nécessaire d&#8217;examiner d&#8217;autres facteurs qui vont au-delà de la perception et une zone d&#8217;opportunité serait de mettre en &#339;uvre des stratégies efficaces pour obtenir des résultats réussi.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Objetivo:  Analisar a percepçâo da capacitaçâo e da aderência em pacientes com diabetes tipo 2 e controle glicêmico em uma unidade de cuidados primários de Tabasco, no México.  Materiais e métodos:  Estudo observacional, transversal e analítico em uma amostra de 100 pacientes com diabetes. Foram analisadas variáveis de percepçâo de empoderamento, adesâo terapéutica, sociodemográficas e clínicas. À medida que a hemoglobina glicosilada HgA1c variável dependente foi feita como ouro controle metabólico padrâo. integrado pela escala DES-28 para avaliar a percepçâo da capacitaçâo questionário percepçâo instrumento para avaliar a adesâo Bayarre-Grau aplicada. Para a análise, estatística descritiva e inferencial (X2 de Pearson) foram utilizadas com o software SPSS V22.0.  Resultados:  Os pacientes com diabetes foram mulheres 72%, idade média de 56 anos, casado 60%, 68% donas de casa, primário 43%, IMC médio de 30,8, a média de anos com diabetes 8.9, principal complicaçâo neuropatía diabética 61% , valor médio de 8,675% hgA1 com figura alterada hgAl 82% dos pacientes com poderes percebidas foram de 86%, destes, 80,2% tinham descontrolada com x2 1.300 e um valor de p = 0,000, com adesâo de 84% destes pacientes foram alterados com o controlo glicémico com um x2 83,3% 0,632 e p = 0,000 Conclusses: Pacientes com poderes e adeptos sâo percebidos ao tratamento em nosso estudo têm controle inadequado da glicemia, o que leva à conclusâo de que é necessário investigar outros fatores que vâo além da percepçâo e uma área de oportunidade seria implementar estratégias eficazes para alcançar resultados sucesso.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Type 2 Diabetes mellitus]]></kwd>
<kwd lng="en"><![CDATA[Self-efficacy]]></kwd>
<kwd lng="en"><![CDATA[Therapeutic adherence]]></kwd>
<kwd lng="en"><![CDATA[Glycosylated hemoglobin (HgAlc)]]></kwd>
<kwd lng="es"><![CDATA[Diabetes mellitus Tipo 2]]></kwd>
<kwd lng="es"><![CDATA[Auto-eficacia]]></kwd>
<kwd lng="es"><![CDATA[Adherencia Terapéutica]]></kwd>
<kwd lng="es"><![CDATA[Hemoglobina glicosilada (HgAlc)]]></kwd>
<kwd lng="fr"><![CDATA[Diabète sucré de type 2]]></kwd>
<kwd lng="fr"><![CDATA[auto-efficacité]]></kwd>
<kwd lng="fr"><![CDATA[adhérence thérapeutique]]></kwd>
<kwd lng="fr"><![CDATA[hémoglobine glycosylée (HgAlc)]]></kwd>
<kwd lng="pt"><![CDATA[Diabetes mellitus de tipo 2]]></kwd>
<kwd lng="pt"><![CDATA[a auto-eficácia]]></kwd>
<kwd lng="pt"><![CDATA[aderência Therapeutics]]></kwd>
<kwd lng="pt"><![CDATA[hemoglobina glicada (HgAlc).]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>International Diabetes Federation</collab>
<source><![CDATA[Diabetes Atlas de La FID]]></source>
<year>2017</year>
<edition>Octava</edition>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chatterjee]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Khunti]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[MJ.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Type 2 diabetes]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2017</year>
<volume>389</volume>
<numero>10085</numero>
<issue>10085</issue>
<page-range>2239-51</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Instituto Nacional de Estadística y Geografía</collab>
<source><![CDATA[Estadísticas de mortalidad]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>Instituto Nacional de Estadística y Geografía</collab>
<source><![CDATA[Estadísticas de mortalidad]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fumagalli]]></surname>
<given-names><![CDATA[L.P]]></given-names>
</name>
<name>
<surname><![CDATA[Radaelli]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lettieri a]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Bertele&#8217;]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Masella]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patient Empowerment and its neighbours: Clarifying the boundaries and their mutual relationships]]></article-title>
<source><![CDATA[Health Policy]]></source>
<year>2015</year>
<volume>3</volume>
<numero>119</numero>
<issue>119</issue>
<page-range>384-94</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Funnell]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[R. Patient]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Empowerment: Myths and Misconceptions]]></article-title>
<source><![CDATA[Patient Educ Couns]]></source>
<year>2010</year>
<volume>3</volume>
<numero>79</numero>
<issue>79</issue>
<page-range>277-82</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alarcón]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Argüelles]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Apoyo social y su asociación con el autocuidado de la dieta en personas con diabetes]]></article-title>
<source><![CDATA[Rev. Liberabit]]></source>
<year>2017</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>111-2</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Serrani]]></surname>
<given-names><![CDATA[DJL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Elders Health Empowerment Scale: Spanish adaptation and psychometric analysis]]></article-title>
<source><![CDATA[Rev. Colombia Médica]]></source>
<year>2014</year>
<volume>4</volume>
<numero>45</numero>
<issue>45</issue>
<page-range>179-85</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Urbán]]></surname>
<given-names><![CDATA[B.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Coghlan]]></surname>
<given-names><![CDATA[J.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estilo de vida y control glucémico en pacientes con Diabetes Mellitus en el primer nivel de atención]]></article-title>
<source><![CDATA[Rev. Atenc. Fam.]]></source>
<year>2015</year>
<volume>22</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>68-71</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrera]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Abad]]></surname>
<given-names><![CDATA[J.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilar]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Rabanaque]]></surname>
<given-names><![CDATA[M.J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comorbilidad como predictor de utilización de servicios sanitarios y mortalidad en pacientes con diabetes]]></article-title>
<source><![CDATA[Gac. Sanit.]]></source>
<year>2015</year>
<volume>29</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>10-4</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Urzúa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Arenas]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Guzmán]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Caqueo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Villalobos]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis preliminares de la versión adaptada en población chilena de la escala de adherencia terapéutica en diabetes mellitus tipo 2 - EATDM-III.]]></article-title>
<source><![CDATA[Rev. méd. Chile]]></source>
<year>2015</year>
<volume>143</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>733-43</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bertoldo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Asear]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Campana]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Martín]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Moretti]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tiscornia]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cumplimiento terapéutico en pacientes eon enfermedades crónicas.]]></article-title>
<source><![CDATA[Rev Cubana Farm]]></source>
<year>2013</year>
<volume>47</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>468-74</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Martín]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Almenares]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia terapéutica y factores influyentes en pacientes con diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Revista Cubana de Medicina General Integral]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[F. López]]></surname>
<given-names><![CDATA[I. Moral.]]></given-names>
</name>
<name>
<surname><![CDATA[A. Aguado]]></surname>
<given-names><![CDATA[C. Cols]]></given-names>
</name>
<name>
<surname><![CDATA[J. Mancera]]></surname>
<given-names><![CDATA[M. Alonso.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impacto de la inercia terapéutica y del grado de adherencia al tratamiento en los objetivos de control en personas con diabetes]]></article-title>
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[M.A]]></given-names>
</name>
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[J.A]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[R. J]]></given-names>
</name>
<name>
<surname><![CDATA[Smalls]]></surname>
<given-names><![CDATA[B.L]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[K. S]]></given-names>
</name>
<name>
<surname><![CDATA[Egede]]></surname>
<given-names><![CDATA[L.E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diabetes empowerment, medication adherence and self-care behaviors in adults with type 2 diabetes]]></article-title>
<source><![CDATA[Diabetes Technology &amp; Therapeutics]]></source>
<year>2012</year>
<volume>14</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>630-4</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Domínguez Mon]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Los cuidados de la salud en personas que viven con diabetes: enfoque etnográfico antropológico y perspectiva de género]]></article-title>
<source><![CDATA[SALUD COLECTIVA]]></source>
<year>2017</year>
<volume>13</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>375-90</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
